If you would like to give to a specific research program or support the work of a particular researcher, contact our fundraising team today.
Professor Stephen Nutt is leading a team that has identified a new genetic target which can destroy multiple myeloma.
Professor Nutt said his team was screening and rigorously testing 260,000 chemical compounds to identify potential compounds that could be developed as potential treatments for people with myeloma.
“We are now in the process of gearing up for the drug screens. On completion, we will figure out what the best candidates are for the development of medicines that could be progressed to clinical trials for patients.”
Associate Professor Edwin Hawkins and his team are combining cell biology and the latest microscopy technologies to study the location, behaviour and interaction of myeloma cells within live tissue.
He said imaging enabled better targeting of treatments, measurement of their impact and understanding of the cancer’s resistance to therapy.
“If we can videotape what is happening within the bone marrow, we will be able to really understand the cell biology that drives multiple myeloma,” he said.
Pete said he and his wife Barb were grateful to be involved with WEHI and learn first-hand about the latest myeloma research.
“We place our hope in WEHI’s medical research and our faith in the generosity of people like you.”
